4Bartmann P, Bamberger U, Pohiandt F, et al. Immunogencity and immunodulatory activity of bovine surfactant(SF-Rll)[J].Acta Paediatr, 1992,81 (5): 383-388.
5Whitsett JA, Hult WM, Luse S, et al. Failture to detect surfactant protein specific antibodies in sera of premature infants treated with survanta. A modified bovine surfactant[J].Pediatrics, 1991,87(4) : 505-510.
6Pickerd N, Kotecha S. The pathophysiology of respiratory distress syndrome. Paediatr Child Health, 2009, 19: 153 - 157.
7Sweet DG, Carnielli V, Greisen G, et al. European consen?sus guidelines on the management of neonatal respiratory dis?tress syndrome in preterm infants - 2010 update. Neonatolo?gy, 2010, 97: 402-417.
8Altman M, Vanpee M, Cnattingius S, et al. Neonatal mor?bidity in moderately preterm infants: A Swedish National Pop?ulation - Based Study.J Pediat , 2011, 158: 239 - 244.
9The Consortium on Safe Labor, HibbardJU, Wilkins I, et al. Respiratory morbidity in late preterm births.JAMA, 2010, 304: 419 - 425.
10Ghartey K, ColettaJ, Lizarraga L, et al. Neonatal respirato?ry morbidity in the early term delivery. AmJ Obstet Gyne- col, 2012, 207: 292. eL'- 292. e4.
